Lack of association between cathepsin D genetic polymorphism and Alzheimer disease in a Spanish sample

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 114, Issue 1, 2002, Pages 31-33

  Mateo, Ignacio ^a   Sánchez Guerra, Marisa ^a   Combarros, Onofre ^a   Llorca, Javier ^b   Infante, Jon ^a   González García, Javier ^c   Del Molino, Jesús Pérez ^d   Berciano, José ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

^c Residencia Personas Mayores Caja Cantabria   (Spain)

^d Centro Hospitalario Benito Menni   (Spain)

Author keywords

Alzheimer disease; Apolipoprotein E; Cathepsin D; Polymorphism

Indexed keywords

APOLIPOPROTEIN E; CATHEPSIN D;

AGED; ALZHEIMER DISEASE; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; MIDDLE AGED; SPAIN; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; CATHEPSIN D; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SPAIN;

EID: 43449088145     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.1623     Document Type: Article

References (12)

1. Bertram L, Guénette S, Jones J, Keeney D, Mullin K, Crystal A, Basu S, Yhu S, Deng A, Rebeck GW. et al. 2001. No evidence for genetic association or linkage of the cathepsin D (CTSD) exon 2 polymorphism and Alzheimer disease. Ann Neurol 49:114-116. (Pubitemid 32163014)
2. Bhojak TJ, DeKosky ST, Ganguli M, Kamboh MI. 2000. Genetic polymorphisms in the catepsin D and interleukin-6 genes and the risk of Alzheimer's disease. Neurosci Lett 288:21-24. (Pubitemid 30408429)
3. Crawford FC, Freeman MJ, Schinka J, Abdullah LI, Richards D, Sevush S, Duara R, Mullan MJ. 2000. The genetic association between Cathepsin D and Alzheimer's disease. Neurosci Lett 289:61-65. (Pubitemid 30433846)
4. Howlett DR, Simmons DL, Dingwall C, Christie G. 2000. In search of an enzyme: the β-secretase of Alzheimer's disease is an aspartic proteinase. Trends Neurosci 23:565-570.
5. Hu Q, Kukull WA, Bressler SL, Gray MD, Cam JA, Larson EB, Martin GM, Deeb SS. 1998. The human FE65 gene: genomic structure and an intronic biallelic polymorphism associated with sporadic dementia of the Alzheimer type. Hum Genet 103:295-303. (Pubitemid 28470080)
6. McIlroy SP, Dynan KB, McGleenon BM, Lawson JT, Passmore AP. 1999. Cathepsin D gene exon 2 polymorphism and sporadic Alzheimer's disease. Neurosci Lett 273:140-141. (Pubitemid 29428127)
7. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. 1984. Clinical diagnosis of Alzheimer disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer Disease. Neurology 24:939-944. (Pubitemid 14076461)
8. Papassotiropoulos A, Bagli M, Feder O, Jessen F, Maier W, Rao ML, Ludwig M, Schwab SG, Heun R. 1999. Genetic polymorphism of catepsin D is strongly associated with the risk for developing sporadic Alzheimer's disease. Neurosci Lett 262:171-174. (Pubitemid 29136797)
9. Papassotiropoulos A, Bagli M, Kurz A, Kornhuber J, Förstl H, Maier W, Pauls J, Lautenschlager N, Heun R. 2000a. A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease. Ann Neurol 47:399-403. (Pubitemid 30141856)
10. Papassotiropoulos A, Bagli M, Becker K, Jessen F, Maier W, Rao ML, Ludwig M, Heun R. 2000b. No association between an intronic biallelic polymorphism of the FE65 gene and Alzheimer's disease. Int J Mol Med 6:587-589.
11. Sadik G, Kaji H, Takeda K, Yamagata F, Kameoka Y, Hashimoto K, Miyanaga K, Shinoda T. 1999. In vitro processing of amyloid precursor protein by cathepsin D. Int J Biochem Cell Biol 31:1327-1337.
12. Selkoe DJ. 2000. The origins of Alzheimer disease: a is for amyloid. JAMA 283:1615-1617.